BandstraE S, MorrowC E, MansoorE and AccorneroV H. 2010. Prenatal drug exposure: infant and toddler outcomes. J Addict Dis, 29: 245–258.
2.
JohnsonJ and LeffM. 1999. Children of substance abusers: overview of research findings. Pediatrics, 103(5 Pt 2): 1085–1099.
3.
JamesonW and HalfonN. 1990. Treatment programs for drug-dependent women and their children. Youth Lab News, 11: 20–21.
4.
Drug-exposed infants. 1995. American Academy of Pediatrics Committee on Substance Abuse. Pediatrics, 96(2 Pt 1): 364–367.
5.
GostinL. 2001. The rights of pregnant women: the Supreme Court and drug testing. Hastings Cent Rep, 31(5): 8–9.
6.
BarthR. 2001. Research outcomes of prenatal substance exposure and the need to review policies and procedures regarding child abuse reporting. Child Welfare, 80: 275–296.
7.
MayesL, GrangerR, BornsteinM and ZuckermanB. 1992. The problem of prenatal cocaine exposure. A rush to judgment. JAMA, 267: 406–408.
8.
American Academy of Obstetricians and Gynecologists. 2004. ACOG Committee Opinion. Number 294, May 2004. At-risk drinking and illicit drug use: ethical issues in obstetric and gynecologic practice. Obstet Gynecol, 103(5 Pt 1): 1021–1031.
9.
American Academy of Obstetricians and Gynecologists. 2008. ACOG Committee Opinion No. 422: At-risk drinking and illicit drug use: ethical issues in obstetric and gynecologic practice. Obstet Gynecol., 112: 1449–1460.
10.
HalbreichU and CarsonS. 1989. Drug studies in women of childbearing age: ethical and methodological considerations. J Clin Psychopharmacol, 9: 328–333.
HowardJ and BeckwithL. 1996. Issues in subject recruitment and retention with pregnant and parenting substance-abusing women. NIDA Res Monogr, 166: 68–86.
